How Prognostic Factors Can Help Manage CLL

Published on

Topics include: Treatment and Understanding

New and emerging prognostic factors are helping researchers to further understand the behavior of CLL. While there is currently not enough data for these factors to directly impact treatment decisions for every CLL patient, research is under way to identify those at high-risk for disease progression who may benefit from early intervention. Dr. William Wierda, clinical medical director in the department of leukemia at MD Anderson Cancer Center, explains this ongoing research and discusses recently discovered genetic mutations, including MYD88 and NOTCH 1, and their potential role in CLL management. 

View more programs featuring

Join Our Community Register for Events Read Our Latest Blog

Page last updated on December 13, 2013